Skip to main content
Norris Cotton Cancer Center
In This Section

Recently Opened Clinical Trials for April 2014

Christopher Amos
Cancer Epidemiology

Department Funded
Tumor tissue molecular map bank

Alexey Danilov
Assistant Professor
Molecular Therapeutics

Alliance-NCI Cooperative Group
A randomized Phase III study of bendamustine plus rituximab versus ibrutinib plus rituximab versus ibrutinib alone in untreated older patients ( ≥ 65 years of age) with Chronic Lymphocytic Leukemia (CLL)

Lionel Lewis
Molecular Therapeutics

Novartis Pharmaceuticals
A Phase Ib, multi-center, two parallel group, open-label, drug-drug interaction study to assess the effect of LDE225 on the pharmacokinetics of bupropion and warfarin in patients with advanced solid tumors